Scandidos
2,26 SEK +0,44 %Vær den første som følger denne virksomhed
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Omsætning
57,68 mio.
EBIT %
-13,21 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SDOS
Daglig lav / høj pris
2,2 / 2,26
SEK
Markedsværdi
93,7 mio. SEK
Aktieomsætning
31,17 t SEK
Volumen
14 t
Finanskalender
Årsrapport
15.06.2023
Viser Alle indholdstyper